Unknown

Dataset Information

0

Age-Related Macular Degeneration (AMD) Transmitochondrial Cybrids Protected from Cellular Damage and Death by Human Retinal Progenitor Cells (hRPCs).


ABSTRACT:

Purpose

One of the leading causes of irreversible blindness worldwide, age-related macular degeneration (AMD) is a progressive disorder leading to retinal degeneration. While several treatment options exist for the exudative form of AMD, there are currently no FDA-approved treatments for the more common nonexudative (atrophic) form. Mounting evidence suggests that mitochondrial damage and retinal pigment epithelium (RPE) cell death are linked to the pathogenesis of AMD. Human retinal progenitor cells (hRPCs) have been studied as a potential restorative therapy for degenerative conditions of the retina; however, the effects of hRPC treatment on retinal cell survival in AMD have not been elucidated.

Methods

In this study, we used a cell coculture system consisting of hRPCs and AMD or age-matched normal cybrid cells to characterize the effects of hRPCs in protecting AMD cybrids from cellular and mitochondrial damage and death.

Results

AMD cybrids cocultured with hRPCs showed (1) increased cell viability; (2) decreased gene expression related to apoptosis, autophagy, endoplasmic reticulum (ER) stress, and antioxidant pathways; and (3) downregulation of mitochondrial replication genes compared to AMD cybrids without hRPC treatment. Furthermore, hRPCs cocultured with AMD cybrids showed upregulation of (1) neuronal and glial markers, as well as (2) putative neuroprotective factors, responses not found when hRPCs were cocultured with age-matched normal cybrids.

Conclusion

The current study provides the first evidence that therapeutic benefits may be obtainable using a progenitor cell-based approach for atrophic AMD. Our results suggest that bidirectional interactions exist between hRPCs and AMD cybrids such that hRPCs release trophic factors that protect the cybrids against the cellular and mitochondrial changes involved in AMD pathogenesis while, conversely, AMD cybrids upregulate the release of these neuroprotective factors by hRPCs while promoting hRPC differentiation. These in vitro data provide evidence that hRPCs may have therapeutic potential in atrophic AMD.

SUBMITTER: Yu JJ 

PROVIDER: S-EPMC7886532 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

Age-Related Macular Degeneration (AMD) Transmitochondrial Cybrids Protected from Cellular Damage and Death by Human Retinal Progenitor Cells (hRPCs).

Yu Jeffrey J JJ   Azzam Daniel B DB   Chwa Marilyn M   Schneider Kevin K   Cho Jang-Hyeon JH   Hsiang Chinhui C   Klassen Henry H   Kenney M Cristina MC   Yang Jing J  

Stem cells international 20210209


<h4>Purpose</h4>One of the leading causes of irreversible blindness worldwide, age-related macular degeneration (AMD) is a progressive disorder leading to retinal degeneration. While several treatment options exist for the exudative form of AMD, there are currently no FDA-approved treatments for the more common nonexudative (atrophic) form. Mounting evidence suggests that mitochondrial damage and retinal pigment epithelium (RPE) cell death are linked to the pathogenesis of AMD. Human retinal pro  ...[more]

Similar Datasets

| S-EPMC5550888 | biostudies-other
| S-EPMC4972370 | biostudies-literature
| S-EPMC2854213 | biostudies-literature
2022-10-19 | GSE215859 | GEO
| S-EPMC7192350 | biostudies-literature
| S-EPMC4053329 | biostudies-literature
| S-EPMC5886461 | biostudies-literature
| S-EPMC4575690 | biostudies-literature
2013-12-23 | E-GEOD-50195 | biostudies-arrayexpress
| S-EPMC3683981 | biostudies-literature